Trials / Completed
CompletedNCT00746226
Probiotics for Birch Pollen Allergy
Probiotic Intervention for Children With Birch Pollen Allergy
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Danisco · Industry
- Sex
- All
- Age
- 2 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
Birch pollen allergy is one of the most common forms of respiratory allergy in the Nordic countries. Treatment consists of antihistamine use. Specific probiotic strains have been observed to modulate the immune system. Since the body has a common mucosal immune system; it was hypothesised that consumption of probiotics may affect also the respiratory mucosal immune response and hence affect respiratory allergy. Earlier studies with probiotics had been unable to show improvements in adults with pollen allergy. It was therefore hypothesised that children, who's immune system is not yet fully developed, might be better targets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Lactobacillus acidophilus and Bifidobacterium lactis | Daily 5x10\^9 CFU of a combination of L. acidophilus and B. lactis |
| BIOLOGICAL | Placebo | Microcrystalline cellulose As capsule which could be opened |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-06-01
- Completion
- 2007-02-01
- First posted
- 2008-09-03
- Last updated
- 2008-09-03
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00746226. Inclusion in this directory is not an endorsement.